SPBC3H7.02 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC3H7.02 antibody; Probable sulfate permease C3H7.02 antibody
Target Names
SPBC3H7.02
Uniprot No.

Target Background

Function
This antibody exhibits high affinity uptake of sulfate into the cell.
Database Links
Protein Families
SLC26A/SulP transporter (TC 2.A.53) family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

Basic Research Questions

  • What is SPBC3H7.02 protein and what does it do in fission yeast?

SPBC3H7.02 is a gene in Schizosaccharomyces pombe (fission yeast) that encodes a probable sulfate permease protein. This protein is predicted to function as a sulfate transporter within the membrane transport system of S. pombe, playing a crucial role in sulfate homeostasis . Understanding this protein's function can provide valuable insights into fundamental cellular processes related to sulfate metabolism and transport in eukaryotic cells. The protein belongs to a family of membrane transporters that are responsible for the movement of sulfate ions across cellular membranes, which is essential for various metabolic pathways.

  • Which applications can SPBC3H7.02 antibodies be used for in research?

According to available data, commercially available SPBC3H7.02 antibodies are primarily suitable for ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot applications . These applications allow researchers to detect and quantify the presence of SPBC3H7.02 protein in cell lysates and other biological samples.

When optimizing these applications, researchers should note that antibodies often work in either western blotting or immunoprecipitation but not necessarily both applications . The commercially available polyclonal antibodies against SPBC3H7.02 are typically produced in rabbit hosts and purified using antigen-affinity techniques, which can provide good specificity when properly validated .

  • How do you validate a commercial SPBC3H7.02 antibody before experiments?

Validation of SPBC3H7.02 antibodies should follow a systematic approach that includes:

  • Testing specificity using positive controls (S. pombe wild-type extracts) and negative controls (ideally SPBC3H7.02 knockout strains)

  • Using standardized characterization approaches with parental and knockout cell lines when available

  • Testing the antibody in the specific application it will be used for (Western blot, ELISA, etc.)

  • Performing concentration titration to determine optimal working dilutions

  • Evaluating cross-reactivity against similar proteins, particularly other sulfate transporters like SPAC869.05c

A comprehensive study of commercial antibody validation found that only 38-80% of antibodies recommended by manufacturers could actually detect their intended targets when rigorously tested . This underscores the importance of thorough validation before conducting critical experiments. Proper validation is especially important since many commercial antibodies show limitations or may be ineffective for detecting endogenous proteins .

  • What are essential controls when using SPBC3H7.02 antibodies?

When working with SPBC3H7.02 antibodies, several essential controls should be incorporated:

  • Positive controls: Wild-type S. pombe extracts where SPBC3H7.02 is known to be expressed

  • Negative controls: Ideally SPBC3H7.02 knockout strains, or if unavailable, knockdown samples using RNAi or CRISPR techniques

  • Multiple antibody validation: Testing several antibodies against the same target can help confirm results

  • Secondary antibody-only control: To check for non-specific binding

  • Recombinant protein control: For quantitative applications, a standard curve using recombinant SPBC3H7.02 protein (if available)

Research indicates that genetic approaches using knockout or knockdown samples are generally more reliable than orthogonal approaches for antibody validation, with 89% of antibodies validated by genetic approaches confirmed to detect their intended targets compared to 80% of those validated by orthogonal methods .

  • How do you optimize Western blot protocols for SPBC3H7.02 detection?

Optimizing Western blot protocols for SPBC3H7.02 detection requires systematic testing of several parameters:

  • Sample preparation: For S. pombe proteins, spheroblasting followed by careful lysis is recommended

  • Protein extraction: Special consideration for membrane proteins like SPBC3H7.02, which may require specific detergents

  • SDS-PAGE conditions: Optimize percentage of acrylamide based on the molecular weight of SPBC3H7.02

  • Transfer conditions: Adjust time and voltage based on protein size

  • Antibody concentration: Test different dilutions, starting with manufacturer's recommendations

  • Blocking conditions: Compare BSA vs. milk to determine which gives lower background

  • Incubation times and temperatures: Test various combinations for primary and secondary antibodies

  • Washing stringency: Adjust salt concentration and detergent levels in wash buffers

It's important to note that Western blot protocols specifically optimized for S. pombe proteins have been documented and can serve as excellent starting points . Additionally, researchers should be aware that some antibodies work well for Western blotting but not for other applications like immunoprecipitation .

  • What is the best method to prepare S. pombe samples for SPBC3H7.02 antibody experiments?

For optimal detection of SPBC3H7.02, sample preparation is crucial:

  • Spheroblasting: The recommended method involves enzymatic digestion of the cell wall, as described in established protocols

  • Membrane protein enrichment: For SPBC3H7.02 (a predicted membrane transporter), cellular fractionation via sucrose density gradient centrifugation can enrich membrane fractions

  • Membrane solubilization: Use appropriate detergents (e.g., Triton X-100, NP-40, or CHAPS) to solubilize membrane proteins without denaturing them

  • Protease protection: Include protease inhibitors in all buffers to prevent protein degradation

  • Topology determination: Proteinase K protection assays can help determine the topology of membrane proteins like SPBC3H7.02

  • Post-translational modification preservation: If analyzing PTMs, include phosphatase inhibitors and avoid harsh denaturing conditions

For SPBC3H7.02, which is predicted to be a membrane protein, careful consideration of detergent type and concentration is essential to maintain protein structure while ensuring efficient extraction from membranes.

Advanced Research Questions

  • How do you troubleshoot cross-reactivity issues with SPBC3H7.02 antibodies?

Troubleshooting cross-reactivity with SPBC3H7.02 antibodies requires a systematic approach:

  • Sequence analysis: Analyze homology between SPBC3H7.02 and other proteins in S. pombe, particularly other sulfate transporters like SPAC869.05c , to identify potential cross-reactive targets

  • Blocking optimization: Try different blocking agents (BSA, milk, commercial blockers) to reduce non-specific binding

  • Washing optimization: Increase stringency with higher salt concentrations or mild detergents

  • Antibody titration: Test higher dilutions of primary antibody to reduce non-specific binding

  • Competitive blocking: If available, use the immunizing peptide to confirm specificity

  • Preabsorption: Preabsorb the antibody with cell lysates from SPBC3H7.02 knockout strains

  • Confirming identity: Use mass spectrometry analysis of immunoprecipitated proteins for definitive identification

Studies have shown that many commercial antibodies show specificity issues , and structural epitope profiling can help understand if your antibody is recognizing common epitopes shared across multiple proteins .

  • What common problems occur with antibodies against fission yeast proteins?

Researchers frequently encounter several challenges when working with antibodies against S. pombe proteins like SPBC3H7.02:

IssueDescriptionPotential Solution
Poor specificityMany commercial antibodies show cross-reactivityTest multiple antibodies, use genetic knockout controls
Weak signalLow abundance of target proteins or poor epitope accessibilityOptimize extraction, try different antibody clones
Batch variabilityInconsistent results between antibody lotsValidate each new lot, maintain reference samples
Application limitationsAntibodies work in one application but not othersValidate specifically for each intended application
Post-translational modificationsPTMs can mask epitopesTry multiple antibodies targeting different regions
Cell wall interferenceComplex cell wall impedes antibody accessOptimize spheroblasting procedures

Research has shown that only a small percentage of commercial antibodies can reliably detect their intended targets . For S. pombe proteins specifically, an evaluation of commercial antibodies found that many showed significant shortcomings or were unacceptable for detecting endogenous proteins .

  • Can SPBC3H7.02 antibodies work in immunofluorescence microscopy?

Using SPBC3H7.02 antibodies for immunofluorescence in fission yeast presents several technical challenges that require specific optimization:

  • Cell wall removal: Proper spheroblasting is crucial - protocols as described for S. pombe are necessary for antibody access

  • Fixation optimization: For membrane proteins like SPBC3H7.02, methanol fixation often preserves epitopes better than formaldehyde

  • Permeabilization balance: Careful control of permeabilization to maintain membrane integrity while allowing antibody access

  • Signal amplification: Consider tyramide signal amplification or similar techniques to enhance detection of low-abundance transporters

  • Specificity controls: Include SPBC3H7.02 knockout or knockdown controls to verify signal specificity

  • How do you determine if SPBC3H7.02 antibodies detect post-translational modifications?

Determining if SPBC3H7.02 antibodies detect post-translational modifications (PTMs) requires several complementary approaches:

  • Enzymatic treatment comparison:

    • Treat samples with specific enzymes that remove PTMs (PNGase F for N-linked glycans, phosphatases for phosphorylations)

    • Compare the molecular weight and antibody recognition before and after treatment

    • S. pombe-specific protocols for EndoH treatment can be particularly informative

  • Parallel detection methods:

    • Run parallel Western blots with antibodies targeting specific PTMs

    • Co-localization of signals suggests PTM-dependent recognition

  • Advanced analysis:

    • Mass spectrometry analysis of immunoprecipitated SPBC3H7.02 can definitively identify PTMs

    • 2D gel electrophoresis can separate protein forms with different modifications

Research on S. pombe proteins has demonstrated the importance of O-mannosylation and N-glycosylation, which could potentially affect SPBC3H7.02 recognition by antibodies . For membrane proteins like SPBC3H7.02, lipid modifications may also be relevant and might require specialized techniques for detection.

  • Why is it challenging to produce antibodies against S. pombe proteins?

The production of antibodies against S. pombe proteins like SPBC3H7.02 faces several significant challenges:

  • Sequence conservation: High sequence similarity to proteins in other species makes it difficult to generate specific antibodies

  • Membrane protein challenges: For SPBC3H7.02, its hydrophobic nature and complex tertiary structure make native antigen preparation difficult

  • Antigen preparation: Expression and purification of full-length membrane proteins for immunization is technically challenging, often requiring peptide fragments

  • Post-translational modifications: Extensive PTMs can shield epitopes or create new ones, affecting antibody recognition

  • Structural complexity: The three-dimensional structure may present few accessible epitopes in the native protein

Approaches to overcome these challenges include using GST-fusion peptides for antibody generation and careful antigen purification strategies . Recent advances in AI-based antibody design approaches might help overcome some of these limitations by predicting optimal epitopes and antibody structures .

  • How does SPBC3H7.02 function in sulfate transport pathways?

Understanding SPBC3H7.02's function in sulfate transport requires multiple complementary approaches:

  • Genetic analysis:

    • Gene deletion or conditional expression systems (similar to nmt81-controlled systems used for other S. pombe genes)

    • Phenotypic analysis under varying sulfate conditions

    • Synthetic lethality screens with other transporter mutants

  • Transport assays:

    • Radioactive sulfate (35S) uptake assays in wild-type versus SPBC3H7.02 mutant strains

    • Competition assays with other sulfate analogs

  • Localization studies:

    • Determine subcellular localization using methods optimized for S. pombe

    • Co-localization with known compartment markers

  • Expression analysis:

    • Transcriptome analysis to reveal expression changes under different sulfate conditions

    • Study how SPBC3H7.02 deletion affects other genes in sulfate metabolism pathways

  • Protein interaction studies:

    • Identify binding partners in the sulfate transport machinery

    • Analyze complex formation with other transporters or regulatory proteins

These methodological approaches have been successfully applied to other S. pombe membrane proteins and could reveal the specific role of SPBC3H7.02 in cellular sulfate homeostasis.

  • Can AI and computational methods improve SPBC3H7.02 antibody design?

AI and computational methods offer promising approaches for improving SPBC3H7.02 antibody design:

  • Structure prediction and epitope mapping:

    • Use AlphaFold-Multimer to predict the 3D structure of SPBC3H7.02

    • Identify accessible, unique epitopes for antibody targeting

    • Analyze sequence conservation to find regions unique to SPBC3H7.02

  • Antibody design platforms:

    • Apply IsAb2.0, an AI-based approach for antibody design that integrates AlphaFold-Multimer and computational tools

    • Use in silico antibody design protocols that address challenges like antigen flexibility

    • Employ structural profiling algorithms like SPACE2 to identify optimal antibody structures

  • Binding optimization:

    • Model antibody-antigen interactions using molecular dynamics simulations

    • Predict binding affinity and specificity to select optimal candidates

    • Apply tools like RosettaAntibodyDesign (RAbD) to sample diverse antibody sequences and structures

Computational approaches can significantly reduce the time and resources needed for traditional trial-and-error antibody development. For SPBC3H7.02, which presents challenges as a membrane protein, computational prediction of accessible epitopes could be particularly valuable.

  • Which regions of SPBC3H7.02 make the best epitope targets for antibodies?

Identifying optimal epitope targets for SPBC3H7.02 antibodies involves several considerations:

  • Structural analysis:

    • For membrane proteins like SPBC3H7.02, extracellular or luminal domains are typically more accessible

    • Hydrophilic regions that protrude from the membrane are preferred targets

    • Loop regions between transmembrane domains often make good epitopes

  • Sequence-based predictions:

    • Regions with high antigenicity scores based on hydrophilicity, surface accessibility, and flexibility

    • Areas with low sequence conservation compared to related proteins to ensure specificity

    • Segments with predicted secondary structures that enhance stability and presentation

  • Experimental mapping approaches:

    • Peptide arrays with overlapping peptides spanning the SPBC3H7.02 sequence

    • Phage display libraries expressing SPBC3H7.02 fragments

    • Topology analysis to identify accessible regions

Computational epitope profiling using structural models has shown promise for identifying optimal epitope targets . For membrane proteins like SPBC3H7.02, understanding protein topology is crucial for selecting accessible epitopes that will be exposed in their native conformation.

  • What is the optimal protocol for immunoprecipitation with SPBC3H7.02 antibodies?

Immunoprecipitation (IP) of membrane proteins like SPBC3H7.02 requires careful optimization:

  • Lysate preparation:

    • Use a mild, non-ionic detergent buffer (1% NP-40 or Triton X-100) with protease inhibitors

    • Consider cellular fractionation to enrich membrane fractions prior to IP

    • Ensure complete solubilization of membrane proteins without denaturing epitopes

  • Pre-clearing and antibody binding:

    • Pre-clear lysate with protein A/G beads to reduce non-specific binding

    • Incubate with SPBC3H7.02 antibody (typically 2-5 μg per mg of protein)

    • Add protein A/G beads to capture antibody-protein complexes

  • Controls and washing:

    • Include non-specific antibody control (same isotype)

    • If possible, include samples from SPBC3H7.02 knockout strains

    • Use increasing salt concentration washes to reduce non-specific binding

  • Elution and analysis:

    • Choose elution method based on downstream applications (acidic, basic, or denaturing)

    • For co-IP studies, use gentler conditions to preserve protein-protein interactions

Research has shown that antibodies that work well for Western blotting may not necessarily work for IP, so specific validation for this application is essential . Multiple optimization rounds may be necessary to establish reliable immunoprecipitation conditions for SPBC3H7.02.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.